Earlier this month, Doximity reported third-quarter fiscal 2026 results showing revenue of US$185.05 million and net income of US$61.56 million, while also issuing fourth-quarter and full-year revenue ...

One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. The accrual ratio subtracts the FCF from the profit for a given period, and ...

Doximity remains a Hold as growth visibility weakens and NRR declines to 112%, raising concerns over future expansion. Engagement and profitability are robust, with workflow tools reaching 720,000 ...

The average one-year price target for Doximity (NYSE:DOCS) has been revised to $44.25 / share. This is a decrease of 31.04% from the prior estimate of $64.16 dated February 1, 2026. The price target ...

Doximity, Inc. (NYSE:DOCS) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. The stock given seventh position on our list of best healthcare stocks is Doximity, Inc.

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, ...

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, ...

Doximity’s latest earnings call painted a picture of a company in strong operational health, balancing robust profitability and cash generation with heavy investment in artificial intelligence and an ...

Teladoc Health leads in virtual healthcare, providing services to more than 100 million U.S. members. CVS Health expands into telehealth, offering 24/7 virtual visits via MinuteClinics. GoodRx ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...